NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 343 filers reported holding NATERA INC in Q2 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,153,000 | -68.1% | 71,950 | -32.0% | 0.18% | -51.8% |
| Q4 2021 | $9,875,000 | -23.9% | 105,739 | -9.2% | 0.36% | -26.8% |
| Q3 2021 | $12,980,000 | +2.5% | 116,479 | +4.4% | 0.50% | +16.7% |
| Q2 2021 | $12,662,000 | +6.0% | 111,529 | -5.2% | 0.42% | -1.2% |
| Q1 2021 | $11,940,000 | -27.2% | 117,589 | -28.7% | 0.43% | -30.0% |
| Q4 2020 | $16,409,000 | -1.3% | 164,879 | -28.3% | 0.61% | -5.7% |
| Q3 2020 | $16,621,000 | +44.4% | 230,079 | -0.3% | 0.65% | +29.9% |
| Q2 2020 | $11,512,000 | +83.8% | 230,885 | +10.0% | 0.50% | +35.0% |
| Q1 2020 | $6,265,000 | – | 209,810 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 881,436 | $48,937,327 | 32.36% |
| Kynam Capital Management, LP | 2,918,237 | $162,020,518 | 20.92% |
| Sofinnova Investments, Inc. | 3,100,560 | $172,143,091 | 11.01% |
| Eversept Partners, LP | 2,819,770 | $156,553,630 | 10.92% |
| Eagle Health Investments LP | 784,894 | $43,577,315 | 8.48% |
| Lagoda Investment Management, L.P. | 162,625 | $9,028,940 | 6.42% |
| BEACONLIGHT CAPITAL, LLC | 204,567 | $11,357,560 | 6.00% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $38,875 | 4.86% |
| PERKINS CAPITAL MANAGEMENT INC | 62,700 | $3,481 | 3.28% |
| RTW INVESTMENTS, LP | 2,611,783 | $145,006,192 | 3.02% |